Tatva Chintan Pharma Chem Shares Rise After Q1 Profit More Than Doubles
Shares of Tatva Chintan Pharma Chem surged over 16% following the company’s Q1 FY27 results, which showed consolidated net profit more than doubling to Rs 16 crore from Rs 7 crore year-on-year. Revenue rose 43% to Rs 167 crore, with EBITDA increasing 86.6% to Rs 32.1 crore and margins expanding to 19.2%. The board approved reappointments of key directors and a Rs 200 crore capacity expansion at its Dahej-III manufacturing unit, to be funded by internal accruals and debt.
First-hand measurement across 6 sources
We measured how 6 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is positive (74/100). Lens Score 36/100.
Outlets measured: businessstandard, moneycontrol, moneycontrol, moneycontrol, moneycontrol, moneycontrol. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (70–75/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
moneycontrol broke this story on 20 Jul, 05:33 am. Other outlets followed.